Atipamezole
From Wikipedia, the free encyclopedia
 |
|
|
Atipamezole
|
|
| Systematic (IUPAC) name | |
| 4-(2-Ethyl-1,3-dihydroinden-2-yl)-3H-imidazole | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C14H16N2 |
| Mol. mass | 212.290 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status |
Veterinary use only |
| Routes | ? |
Atipamezole (brand name Antisedan, Pfizer) is a synthetic alpha2-adrenergic antagonist, indicated for the reversal of the sedative and analgesic effects of dexmedetomidine hydrochloride and medetomidine hydrochloride in dogs.[1]
[edit] References
[edit] External links
 |
This veterinary medicine related article is a stub. You can help by expanding it. |
